key: cord-0954716-v67g2g1c authors: Raiden, S.; Cairoli, H.; Potasnik, J.; Di Lalla, S.; Chiolo, M. J.; Torres, F. A.; Dominguez, P.; Ferrero, F. title: Children hospitalized for COVID-19 during first winter of the pandemic in Buenos Aires, Argentina date: 2020-11-06 journal: nan DOI: 10.1101/2020.11.05.20225300 sha: caca20653a48e9cc3d7d683fa49ea65ae9794623 doc_id: 954716 cord_uid: v67g2g1c Background: Although there are reports on COVID-19 in pediatrics, it is possible that the characteristics of each population, their health systems and how they faced the pandemic made the disease show distinctive features in different countries. We aimed to describe the characteristics of patients hospitalized for COVID-19 in a tertiary pediatric hospital in the City of Buenos Aires, Argentina. Methods: Descriptive study, including all patients hospitalized for COVID-19 in a tertiary pediatric hospital, from 04/26/2020 to 10/31/2020. Demographic, clinical and epidemiological characteristics of the patients are described. Results: In the studied period 578 children and adolescents were hospitalized for COVID-19. The median age was 4.2 years and 83% had a history of close contact with a confirmed COVID-19 case. Regarding severity, 30.8% were asymptomatic, 60.4% mild, 7.4% moderate, and 1.4% severe. Among those with symptoms, the most frequent was fever, followed by sore throat and cough. Conclusion: We reported 578 cases of children and adolescents hospitalized for COVID-19, most of them showed a mild or asymptomatic condition. Despite the COVID-19 pandemic has caused hundreds of thousands of deaths worldwide, the information available to date shows that the disease is less severe in the pediatric population [1, 2] . Also, there are reports that seem to show that the development of the pandemic may be influenced by the characteristics of each country, their health systems and how they faced the pandemic [3, 4] . In addition to the characteristics of their own population and health system, Argentina faced the pandemic in a particular way, including the longest lockdown [5] and mandatory hospitalization of affected infants, regardless of its severity [6] . These characteristics could give a distinctive feature to children hospitalized for this disease. We aimed to describe the characteristics of patients hospitalized for COVID-19 in a pediatric tertiary hospital in the City of Buenos Aires. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint Lab tests were also recorded (hemoglobin, differential WBC count, platelets, C-reactive protein, and erythrocyte sedimentation rate). Analysis: Categorical variables are described by proportions with 95% confidence intervals (95% CI) and continuous variables with mean and standard deviation or median and interquartile range, according to distribution (Kolmogorov-Smirnov test). IBM SSPS Statistics 20.0 was used. The study was approved by the Institution Ethics Committee. In the studied period, 578 children and adolescents were hospitalized for COVID-19. The number of hospitalizations per week ranged between 2 and 42. (Figure 1 ) The median age was 4.2 (IIC: 0.7-11.2) years and 54.5% were male. Sixty-seven percent (67.3%) had their residence within the jurisdiction of the hospital (City of Buenos Aires) and, of them, 23.1% lived in a poor neighborhood. Eighty-three percent (83%) had a history of close contact with a confirmed COVID-19 case. The time of symptoms onset before admission was 1 day (IIC: 1-3). Thirty-five percent (35.3%) had a previous or concomitant diagnosis of other disease, asthma being the most frequent (n = 49) ( Table 1) . Disease severity was assessed and 30.8% were considered asymptomatic, 60.4% mild, 7.4% moderate, and 1.4% severe. From the six severe cases, only one required assisted ventilation, and two presented with SARS-CoV-2-related multisystemic inflammatory syndrome (MIS-C). Other six MIS-C cases were admitted to the hospital but SARS-CoV-2 testing was negative. The most frequent initial symptom was fever, followed by sore throat and cough ( is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint Regarding the lab tests, we found that 9% showed lymphopenia (lymphocyte differential count <20%) and 23.8% elevated C-reactive protein values (C-reactive protein > 10 mg/dl) (being 100% among severe cases and 10% among asymptomatics)( Table 3 ). The length of stay had a median of 6 days (IIC: 2.2-9). At the time of this report, only one patient with COVID 19 died, due to causes other than the disease, since he was in end-of-life care. All patients were discharged without complications (with phone follow-up), except those whose comorbidity prevented it. Our study strengthens the idea that COVID 19 in pediatrics is, in general, mild. It also supports some characteristics of the disease in Argentina that a previous report has suggested [9] . Although it is possible that the age structure (Argentina has twice the number of children under 15 years of age than Italy) and the social behaviour of the different populations influence the differences observed [10] [11], the way in which local health authorities dealt with the pandemic have generated some particular features in our patients. We found more pediatric cases than other countries and a higher proportion of asymptomatic and mild among those hospitalized. The City of Buenos Aires, adopted a "test and trace" policy. This program was carried out more strongly in poor neighborhoods, which have a younger population [12] . Mandatory hospitalization was also established for infants, still asymptomatic [6] [13] . Furthermore, those asymptomatic children and adolescents who did not have home conditions to comply with out-of-hospital isolation, were hospitalized for the isolation period [14] . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint In the period covered by this report (until 10/31/2020) the City of Buenos Aires reported 147,363 cases, of which 12.1% were children and adolescents [15] , a substantially higher proportion than that initially reported in China (2.1 %) [16] and Italy [17] , but closer to that lately reported in the USA (9%) [18] . We found a high proportion of asymptomatic patients (30.8%), higher than that reported by Götzinger in Europe in 582 children with SARS-CoV-2 infection (16%) [19] , probably related to the above mentioned test and trace and institutional isolation policies adopted by the health authorities. We only found 5.6% moderate and 1.2% severe cases. Dong et al. in China reported 5.9% severe and critical cases [8] and Tagarro in Spain reports that 9.7% of the cases in his series were severe [20] . Although a report from the United States showed that 32% of hospitalized pediatric patients with COVID-19 were admitted to the PICU, the limited average length of stay (2 days) and the limited proportion of subjects who required assisted ventilation (5.8%) suggests that the admission criteria in this series were broader [21] . Regarding the cases of MIS-C (COVID-19 associated Multisystem Inflammatory Syndrome in Children) that we report, they presented 4 to 6 weeks after reaching a significant number of cases in our city, a moment described as usual for the development of this complication [22] . Finally, we have that 83% of our patients had close contact with infected people, supporting the idea that children are usually infected from adults [23] . This study has the limitation of presenting data from a single center, although it is probably the public institution that has hospitalized the most pediatric patients with COVID-19 in our country. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint In this study we report 578 cases of children and adolescents hospitalized for COVID-19 in Argentina. Most presented their disease as mild or asymptomatic. . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 6, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint Surgical conditions (appendicitis, testicular torsion, hernias) 12 Seizures 11 Non-progressive chronic encephalopathy 11 Genetic disorders 9 Tumors 8 Tuberculosis 8 Other infections (otitis, celulitis, hepatitis) 8 Urinary tract infection 7 Obesity 5 Diabetes mellitus 5 Thrombocytopenic purpura 5 Chronic kidney injury 5 Chronic lung disease/Bronchopulmonary dysplasia 4 11 . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults COVID-19 in 7780 pediatric patients: A systematic review Winter Is Coming: A Southern Hemisphere Perspective of the Environmental Drivers of SARS-CoV-2 and the Potential Seasonality of COVID-19 Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide Coronavirus: Argentina 's never-ending quarantine. Deutsche Welle Manejo frente a casos sospechosos y confirmados de coronavirus (COVID 19) en pediatría Manejo frente a casos sospechosos y confirmados de coronavirus (COVID 19). V.30. 7 de Junio de 2020 Manejo frente a casos sospechosos y confirmados de coronavirus (COVID 19). V.32. 19 de Junio de 2020 Actualización de los casos de coronavirus en la Ciudad The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) -China Coronavirus Disease 2019 (COVID-19) in Italy Demographic Trends of COVID-19 cases and deaths in the US reported to CDC Tebruegge M; ptbnet COVID-19 Study Group. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 -COVID-NET, 14 States COVID-19 and multisystem inflammatory syndrome in children and adolescents Children are not COVID-19 super spreaders: time to go back to school Hematologic disease (spherocytosis, hemophilia) 2 HIV 2Other 4812 . CC-BY-ND 4.0 International license It is made available under a perpetuity.is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted November 6, 2020. ; https://doi.org/10.1101/2020.11.05.20225300 doi: medRxiv preprint